Comparison of two radiotherapeutic hypofractionated schedules in the application of tumor bed boost

Clinical Breast Cancer

Volumn 13, Issue 4, 2013, Pages 292-298

  Zygogianni, Anna ^a   Kouloulias, Vassilios ^b   Kyrgias, George ^c   Armpilia, Christina ^a   Antypas, Christos ^a   Theodorou, Kiki ^c   Kouvaris, John ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Breast cancer; Concomitant; Radiotherapy; Sequential; Toxicity; Tumor bed

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PHOTON THERAPY; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RETROSPECTIVE STUDY; SKIN TOXICITY; TREATMENT PLANNING;

EID: 84884702323     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2013.02.007     Document Type: Article

References (44)

1. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002;94:1143-50.
2. Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: longterm results of a randomised trial. Lancet Oncol 2006;7:467-71.
3. Olivotto IA, Weir L M L, Kim-Sing C, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 1996;41:7-13.
4. Poortmans P, Bartelink H, Horiot JC, et al. The influence ofthe boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. Radiother Oncol 2004;72:25-33.
5. Polgar C, Fodor J, Orosz Z, et al. The effect of tumour bed boost on local control after breast conserving surgery. First results randomized boost trial of the National Institute Oncology, Magy Onkol 2001;45:385-91.
6. Romestaing P, Lehingue Y, Carrie C, et al. Role ofa 10-Gyboostin theconservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997;15:963-8.
7. Offersen BV, Overgaard M, Kroman N, et al. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 2009;90:1-12.
8. Van Der Laan HP, Dolsma WV, Maduro JH, et al. Three dimensional conformal simultaneously integrated boost technique for breast conserving radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1018-23.
9. Teh AY, Walsh L, Purdie TG, et al. Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy: a feasibility and toxicity study. Radiother Oncol 2012;102:89-95.
10. Raza S, Lymberis SC, Ciervide R, et al. Comparison of acute and late toxicity of two regimens of 3-and 5-week concomitant boost prone IMRT to standard 6 week breast radiotherapy. Front Oncol 2012;2:44.
11. Zygogianni AG, Kouloulias V, Armpilia C, et al. The potential role of hypofractionated accelerated radiotherapy to cosmesis for stage I-II breast carcinoma: a prospective study. J BUON 2011;16:58-63.
12. International Commission on Radiation Units and Measurements (ICRU). Report 62. Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). Bethesda, MD: ICRU; 1999.
13. Bentzen SM, Constine LS, Deasy JO, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010;76:3-9.
14. Armpilia C, Antypas C, Zygogianni A, et al. A review on radiotherapy hypofractionation schedules for breast cancer treatment. J Radiother Practice 2011;10:201-8.
15. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005;75:9-17.
16. Kurtz JM. The clinical radiobiology of breast cancer radiotherapy. Radiother Oncol 2005;75:6-8.
17. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
18. Rubin P, Constine LS, Fajardo LF, et al. RTOG Late Effects Working Group. Overview: Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995;31:1041-2.
19. Bartelink H, Horiot JC, Poortmans P, et al. Radiotherapy and breast cancer groups, recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378-87.
20. Bartelink H, Horiot CJ, Poortmans P, et al. Impact of radiation dose on local control, fibrosis and survival after breast conserving treatment: 10 years results of the EORTC trial 22881-10882. Breast Cancer Res Treat 2006;100(suppl 1):A-10, S8.
21. Graham P, Fourquetz A. Placing the boost in the breast conservation radiotherapy: a review of the role, indications and techniques for breast boost radiotherapy. Clin Oncol 2005;18:210-9.
22. Polgar C, Fodor J, Major T, et al. The role of boost irradiation in the conservative treatment of stage I-II breast cancer. Pathol Oncol Res 2001;7:241-50.
23. Bates AT, Swift CL, Kwa W, et al. A computed tomography-based protocol vs conventional clinical mark-up for breast electron boost. Clin Oncol (R Coll Radiol) 2007;19:349-55.
24. Kirova YM, Castro Pena P, Hijal T, et al. Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients. Int J Radiat Oncol Biol Phys 2010;78:1-4.
25. Smitt MC, Birdwell RL, Goffinet DR. Breast electron boost planning: comparison of CT and US. Radiology 2001;219:203-6.
26. Ringash J, Whelan T, Elliott E, et al. Accuracy of ultrasound in localization ofbreast boost field. Radiother Oncol 2004;72:61-6.
27. Kirova YM, Fournier-Bidoz N, Servois V, et al. How to boost the breast tumor bed? A multidisciplinary approach in eightsteps. Int J Radiat Oncol Biol Phys 2008;72:494-500.
28. Al Uwini S, Antonini N, Poortmans PM, et al. The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment. Radiother Oncol 2009;93:87-93.
29. Chadha M, Vongtama D, Friedmann P, et al. Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer. Clin Breast Cancer 2012;12:57-62.
30. Woo TC, Pignol JP, Rakovitch E, et al. Body radiation exposure in breast cancer radiotherapy: impact ofbreast IMRT and virtual wedge compensation techniques. Int J Radiat Oncol Biol Phys 2006;65:52-8.
31. Cante D, Rosa La Porta M, Casanova-Borca V, et al. Accelerated hypofractionated adjuvantwhole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients. Breast J 2011;17:586-93.
32. Guenzi M, Vagge S, Che Azinwi N, et al. A biologically competitive 21 days hypofraction feasibility acute subacuteandshort termlateeffects. Radiol Oncol 2010;5:111.
33. Morganti AG, Cilla S, Valentini V, et al. Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. Radiother Oncol 2009;90:86-92.
34. Conway L, Tsang Y, on behalf of the IMPORT Trial Management Group. Forward-planning solution for the IMPORT HIGH breast IMRT trial. Clin Oncol 2007;19:S15.
35. Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys 2000;48:1559-68.
36. Landau D, Adams EJ, Webb S, et al. Cardiac avoidance in breast radiotherapy: a comparison ofsimple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol 2001;60:247-5.
37. Marcenaro M, Sacco S, Pentimalli S, et al. Measures of late effects in conservative treatment ofbreast cancer with standard or hypofractionated radiotherapy. Tumori 2004;90:586-91.
38. Singla R, King S, Albuquerque K, et al. Simultaneous-integrated boost intensitymodulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma. Med Dosim 2006;31:190-6.
39. Thilmann C, Zabel A, Nill S, et al. Intensity-modulated radiotherapy of the female breast. Med Dosim 2002;27:79-90.
40. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:1336-44.
41. Mihai A, Rakovitch E, Sixel K, et al. Inverse vs. forward breast IMRT planning. Med Dosim 2005;30:149-54.
42. Plataniotis GA, Theofanopoulou ME, Sotiriadou K, et al. High resolution computed tomography findings on the lung of early breast-cancer patients treated by postoperative breast irradiation with a hypofractionated radiotherapy schedule. Indian J Cancer 2005;42:191-6.
43. Probst H, Griffiths S. Moving to a high-tech approach to the irradiation of early breast cancer: is it possible to balance efficacy, morbidity and resource use? Clin Oncol (R Coll Radiol) 2006;18:268-75.
44. Van Asselen B, Raaijmakers CP, Hofman P, et al. An improved breast irradiation technique using three-dimensional geometrical information and intensity modulation. Radiother Oncol 2001;58:341-7.